Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: a meta-analysis

BACKGROUND: There is still a debate regarding whether regimens combining irinotecan with platinum could replace regimens combining etoposide with platinum, as first-line chemotherapy for extensive-stage small cell lung cancer (ES-SCLC). We performed a meta-analysis to compare these regimens as first...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Fei, Ren, Xiaoli, Chen, Yuan, Li, Qianxia, Li, Ruichao, Chen, Yu, Xia, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086076/
https://www.ncbi.nlm.nih.gov/pubmed/30097029
http://dx.doi.org/10.1186/s12885-018-4715-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086076/
https://www.ncbi.nlm.nih.gov/pubmed/30097029
http://dx.doi.org/10.1186/s12885-018-4715-9

Ejemplares similares